- Home
- / Innovate Biopharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Innovate Biopharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Total Funding
$30.7 M
Revenue
$1.9 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.1M | 1.9M | |||||
| Cost of goods sold | 3.3M | 1.9M | |||||
| Gross profit | 736.0K | (64.0K) | |||||
| Gross profit margin, % | 18.1% | -3.4% | |||||
| General and administrative expense | 4.0M | 5.0M | 10.7M | 10.6M | 10.5M | 9.7M | 11.0M |
| Operating expense total | 6.7M | 8.9M | 18.2M | 24.3M | 21.5M | 42.0M | |
| EBIT | (5.9M) | (9.0M) | 18.2M | 25.5M | (60.9M) | (36.8M) | (42.0M) |
| EBIT margin, % | -146.2% | -475.4% | |||||
| Interest income | 163.8K | 185.3K | 19.0K | 22.7K | 501.2K | ||
| Interest expense | 825.0K | 93.0K | |||||
| Pre tax profit | (6.2M) | (7.9M) | (24.2M) | (27.0M) | (61.5M) | (36.8M) | (43.8M) |
| Income tax expense | 2.0K | ||||||
| Net Income | (6.2M) | (7.9M) | (24.2M) | (27.0M) | (61.5M) | (36.8M) | (43.8M) |
| EPS | (3.4) |